Covered recipient · General Payments record
SHARI HARDING
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$2,203.82
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $787.87 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $255.92 | 3 |
| ABBVIE INC. | $160.95 | 2 |
| GlaxoSmithKline, LLC. | $125.00 | 1 |
| Acerta Pharma LLC | $99.12 | 1 |
| ViiV Healthcare Company | $76.11 | 1 |
| ACADIA Pharmaceuticals Inc | $70.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $76.69 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107288186 | CMS |
| ABBVIE INC. | $84.26 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107288188 | CMS |
| ACADIA Pharmaceuticals Inc | $70.77 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148004886 | CMS |
| AstraZeneca Pharmaceuticals LP | $99.12 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104370723 | CMS |
| GlaxoSmithKline, LLC. | $125.00 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116512037 | CMS |
| Neurocrine Biosciences, Inc. | $76.80 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150926827 | CMS |
| Neurocrine Biosciences, Inc. | $93.78 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150926029 | CMS |
| Neurocrine Biosciences, Inc. | $85.34 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150926497 | CMS |
| ViiV Healthcare Company | $76.11 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112826423 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.